Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum
NCT ID: NCT06744491
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2024-12-20
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
No interventions assigned to this group
Adolescent
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
No interventions assigned to this group
Young Adults
Young adults as defined by chronological age between ages 18 - 35 years
No interventions assigned to this group
Older Adults
Older adults as defined by chronological age between ages 60 - 80 years
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
* Chronological age between 8 to 16 years, with maturity offset \< -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
* BMI between normal to overweight (18.5 - 29.9 kg/m2)
Exclusion Criteria
* use of anticoagulants
* use of a walker, cane, or assistive walking device
* infectious or gastrointestinal disease
* inability to comply with study protocol (e.g., unable to track diet)
* regular tobacco use
* self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
* diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
* pregnant
* hormonal replacement therapy
8 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Moore
Professor, Muscle Physiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Goldring Center for High Performance Sport
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hugo JW Fung, PhD Candidate
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00044004
Identifier Type: -
Identifier Source: org_study_id